1Mueller C,Scholer A, Laule-Kilian K, et al. Use of B-type natriuretic peptide in lhe evaluation and management of acute dyspnea [ J]. N Engl J Med,2004,350:647-654. 被引量：1
2Levy D, Kenchaiah S, Larson MG, et al. Long-term trends in the incidence of and survival with heart failure [ J]. N Engl J Med, 2002,347:1397-1402. 被引量：1
3Cowie MR, Fox KF, Wood DA, et al. Hospitalization of patients with heart failure: a population-based study [J]. Eur Heart J, 2002,23:877-885. 被引量：1
4Silver MA, Maisel A, Yancy CW, et al. BNP consensus panel 2004 : a clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases [ J ]. Congest Heart Fail ,2004,10 ( suppl 3) :1-30. 被引量：1
5Maisel AS, McCullough PA. Cardiac natriuretic peptides: a proteomic window to cardiac function and clinical management[ J]. Rev Cardiovasc Mcd ,2003,4( suppl 4) :S3-S12. 被引量：1
6Melanson SE, Lewandrowski EL. Laboratory testing for B-type natriuretic peptides( BNP and NT-proBNP) :clinical usefulness, utilization,and impact on hospital operations [ J ]. Am J Clin Pathol, 2005,124(suppl) :S122-S128. 被引量：1
7Maisel AS, Krishnaswamy P, Nowak RM,et al. Rapid measurement of B-lype natriuretic peptide in the emergency diagnosis of heart failure[ J]. N Engl J Med ,2002,347 : 161-167. 被引量：1
8Boust JA, Glasziou PP, Pietrzak E, et al. A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure [ J ]. Arch Intern Med, 2004,164 : 1978-1984. 被引量：1
9Doust JA,Pietrzak E, Dobson A, et al. How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure : systematic review[ J ]. BMJ ,2005,330:625. 被引量：1
10McDonagh TA, Cunningham AD, Morrison CE, et al. Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population [ J ]. Heart,2001,86:21-26. 被引量：1
